The FDA announced that it issued emergency use authorization (EUA) for the first at-home, rapid COVID-19 diagnostic test.
A diagnostic designed for self-testing in the home, the Lucira COVID-19 all-in-one test kit is a molecular (real-time loop-mediated amplification reaction) single-use test designed to detect SARS-CoV-2, according to an FDA news release.
Get the full story at our sister site, MassDevice.
Filed Under: Drug Discovery, Infectious Disease
Tell Us What You Think!
You must be logged in to post a comment.